nach oben

Erschienen in:

01.06.2008 | Original Article

Effectiveness of the AUDIT-C as a Screening Test for Alcohol Misuse in Three Race/Ethnic Groups

verfasst von: Danielle Frank, MD, MPH, Anna F. DeBenedetti, BA, Robert J. Volk, PhD, Emily C. Williams, MPH, Daniel R. Kivlahan, PhD, Katharine A. Bradley, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Summary

Background

The Alcohol Use Disorders Identification Test—Consumption (AUDIT-C) is a brief validated screen for risky drinking and alcohol abuse and dependence (alcohol misuse). However, the AUDIT-C was validated in predominantly White populations, and its performance in different racial/ethnic groups is unclear.

Objective

To evaluate the validity of the AUDIT-C among primary care patients from the predominant racial/ethnic subgroups within the United States: White, African American, and Hispanic.

Design

Cross-sectional interview validation study.

Participants

1,292 outpatients from an academic family practice clinic in Texas (90% of randomly sampled eligible).

Measurements and Main Results

Race/ethnicity was self-reported. Areas under the receiver operating curve (AuROCs) evaluated overall AUDIT-C performance in the 3 racial/ethnic groups compared to diagnostic interviews for alcohol misuse. AUDIT-C sensitivities and specificities at recommended screening thresholds were compared across racial/ethnic groups. AuROCs were greater than 0.85 in all 3 groups, with no significant differences across racial/ethnic groups in men (P = .43) or women (P = .12). At previously recommended cut points, there were statistically significant differences by race in AUDIT-C sensitivities but not specificities. In women, the sensitivity was higher in Hispanic (85%) than in African-American (67%; P = .03) or White (70%; P = .04) women. In men, the sensitivity was higher in White (95%) than in African-American men (76%; P = .01), with no significant difference from Hispanic men (85%; P = .11).

Conclusions

The overall performance of the AUDIT-C was excellent in all 3 racial/ethnic groups as reflected by high AuROCs. At recommended cut points, there were significant differences in the AUDIT-C’s sensitivity but not in specificity across the 3 racial/ethnic groups.

Nur mit Berechtigung zugänglich

Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.PubMedCrossRef

Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.PubMedCrossRef

Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA. 1997;277(13):1039–45.PubMedCrossRef

Wallace P, Cutler S, Haines A. Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. BMJ. 1988;297(6649):663–8.PubMedCrossRef

Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–68.PubMed

Kaner E, Beyer F, Dickinson H, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;(2):CD004148.

U.S. Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: Recommendation statement. Ann Intern Med. 2004;140:554–6.

Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252(14):1905–7.PubMedCrossRef

Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1–10.CrossRef

10.

Cherpitel CJ, Clark WB. Ethnic differences in performance of screening instruments for identifying harmful drinking and alcohol dependence in the emergency room. Alcohol Clin Exp Res. 1995;19(3):628–34.PubMedCrossRef

11.

Volk RJ, Cantor SB, Steinbauer JR, Cass AR. Item bias in the CAGE screening test for alcohol use disorders. J Gen Intern Med. 1997;12(12):763–9.PubMedCrossRef

12.

Cherpitel CJ. Differences in performance of screening instruments for problem drinking among blacks, whites and Hispanics in an emergency room population. J Stud Alcohol. 1998;59(4):420–6.PubMed

13.

Steinbauer JR, Cantor SB, Holzer CE 3rd, Volk RJ. Ethnic and sex bias in primary care screening tests for alcohol use disorders. Ann Intern Med. 1998;129(5):353–62.PubMed

14.

Cherpitel CJ. Screening for alcohol problems in the U.S. general population: a comparison of the CAGE and TWEAK by gender, ethnicity, and services utilization. J Stud Alcohol. 1999;60(5):705–11.PubMed

15.

Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II. Addiction. 1993;88(6):791–804.PubMedCrossRef

16.

National Institute on Alcohol Abuse and Alcoholism, UDoHaHS, National Institute of Health. Helping Patients Who Drink Too Much: A Clinician’s Guide. Baltimore, MD: National Institute of Health; 2005.

17.

Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.PubMedCrossRef

18.

Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–9.PubMedCrossRef

19.

Volk RJ, Steinbauer JR, Cantor SB, Holzer CE 3rd. The Alcohol Use Disorders Identification Test (AUDIT) as a screen for at-risk drinking in primary care patients of different racial/ethnic backgrounds. Addiction. 1997;92(2):197–206.PubMedCrossRef

20.

Chatterji S, Saunders JB, Vrasti R, Grant BF, Hasin D, Mager D. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule—Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend. 1997;47(3):171–85.PubMedCrossRef

21.

Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195–205.PubMedCrossRef

22.

Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37–44.PubMedCrossRef

23.

Ustun B, Compton W, Mager D, et al. WHO study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend. 1997;47(3):161–9.PubMedCrossRef

24.

Fiellin DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160(13):1977–89.PubMedCrossRef

25.

Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43–6.PubMedCrossRef

26.

Perneger TV. What’s wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236–8.PubMed

27.

Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Method. 2002;2:8.CrossRef

28.

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.PubMedCrossRef

29.

Bischof G, Reinhardt S, Grothues J, et al. Effects of item sequence on the performance of the AUDIT in general practices. Drug Alcohol Depend. 2005;79(3):373–7.PubMedCrossRef

30.

Dawson DA, Grant BF, Stinson FS, Chou PS. Toward the attainment of low-risk drinking goals: a 10-year progress report. Alcohol Clin Exp Res. 2004;28(9):1371–8.PubMedCrossRef

31.

Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res. 2005;29(5):844–54.PubMedCrossRef

32.

Cherpitel CJ. Comparison of screening instruments for alcohol problems between black and white emergency room patients from two regions of the country. Alcohol Clin Exp Res. 1997;21(8):1391–7.PubMed

33.

Cherpitel CJ. Gender, injury status and acculturation differences in performance of screening instruments for alcohol problems among US Hispanic emergency department patients. Drug Alcohol Depend. 1999;53(2):147–57.PubMedCrossRef

34.

Seale JP, Boltri JM, Shellenberger S, et al. Primary care validation of a single screening question for drinkers. J Stud Alcohol. 2006;67(5):778–84.PubMed

35.

Caetano R. Alcohol use among Hispanic groups in the United States. Am J Drug Alcohol Abuse. 1988;14(3):293–308.PubMedCrossRef

36.

Cherpitel CJ, Bazargan S. Screening for alcohol problems: comparison of the audit, RAPS4 and RAPS4-QF among African American and Hispanic patients in an inner city emergency department. Drug Alcohol Depend. 2003;71(3):275–80.PubMedCrossRef

37.

Cherpitel CJ, Borges G. Screening instruments for alcohol problems: a comparison of cut points between Mexican American and Mexican patients in the emergency room. Subst Use Misuse. 2000;35(10):1419–30.PubMedCrossRef

38.

Williams R, Vinson DC. Validation of a single screening question for problem drinking. J Fam Pract. 2001;50(4):307–12.PubMed

39.

Bradley KA, McDonell MB, Bush K, Kivlahan DR, Diehr P, Fihn SD. The AUDIT alcohol consumption questions: reliability, validity, and responsiveness to change in older male primary care patients. Alcohol Clin Exp Res. 1998;22(8):1842–9.PubMed

40.

Bradley KA, Kivlahan DR, Zhou XH, et al. Using alcohol screening results and treatment history to assess the severity of at-risk drinking in Veterans Affairs primary care patients. Alcohol Clin Exp Res. 2004;28(3):448–55.PubMedCrossRef

41.

Au DH, Kivlahan DR, Bryson CL, Blough D, Bradley KA. Alcohol screening scores and risk of hospitalizations for GI conditions in men. Alcohol Clin Exp Res. 2007;31(3):443–51.PubMedCrossRef

42.

American Psychiatric Association. American Psychiatric Association. Task Force on DSM-IV.. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4Washington, DC: American Psychiatric Association; 2000.

Titel: Effectiveness of the AUDIT-C as a Screening Test for Alcohol Misuse in Three Race/Ethnic Groups
verfasst von: Danielle Frank, MD, MPH
Anna F. DeBenedetti, BA
Robert J. Volk, PhD
Emily C. Williams, MPH
Daniel R. Kivlahan, PhD
Katharine A. Bradley, MD, MPH
Publikationsdatum: 01.06.2008
Verlag: Springer-Verlag
Erschienen in: Journal of General Internal Medicine / Ausgabe 6/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-008-0594-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Summary

Background

Objective

Design

Participants

Measurements and Main Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2008

Barriers to Screening Colonoscopy for Low-income Latino and White Patients in an Urban Community Health Center

Effects of Disclosing Financial Interests on Attitudes Toward Clinical Research

Stop Orders to Reduce Inappropriate Urinary Catheterization in Hospitalized Patients: A Randomized Controlled Trial

A Case of Occult Compartment Syndrome and Nonresolving Rhabdomyolysis

Physician Reminders to Promote Surveillance Colonoscopy for Colorectal Adenomas